top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

TARS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.54%

Insider Buying (Last 12 Months): $178,660.80

Insider Selling (Last 12 Months): $5,584,852.48

Tarsus Pharmaceuticals Insider Trading History Chart

Tarsus Pharmaceuticals Share Price & Price History

^$33.71

▲ +1.42 (4.40%)

As of 04/23/2024 01:00 AM ET

Days: 30 | 90 | 365

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

From Banyan Hill Publishing | Ad

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

Tarsus Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2024	Aziz Mottiwala	Insider	Sell	4,766	$30.60	$145,839.60	54,075
3/18/2024	Bobak R. Azamian	CEO	Sell	10,415	$30.60	$318,699.00	26,456
3/18/2024	Bryan Wahl	General Counsel	Sell	4,436	$30.60	$135,741.60	40,951
3/18/2024	Seshadri Neervannan	COO	Sell	4,879	$30.60	$149,297.40	64,767
12/27/2023	Bobak R. Azamian	CEO	Sell	8,000	$20.22	$161,760.00	830,106
12/20/2023	Bobak R. Azamian	CEO	Sell	40,000	$20.27	$810,800.00	838,106
12/20/2023	Jose M Trevejo	Insider	Sell	2,252	$20.00	$45,040.00	2,251
12/15/2023	Andrew D Goldberg	Director	Buy	1,000	$18.96	$18,960.00	3,000
11/30/2023	Bryan Wahl	General Counsel	Sell	8,356	$16.31	$136,286.36	31,966
11/30/2023	Dianne C Whitfield	Insider	Sell	8,355	$16.31	$136,270.05	26,784
10/18/2023	Bobak R. Azamian	CEO	Sell	8,000	$13.24	$105,920.00	886,106
10/5/2023	Jose M Trevejo	Insider	Sell	1,604	$18.00	$28,872.00	4,503
9/20/2023	Bobak R. Azamian	CEO	Sell	8,000	$17.21	$137,680.00	894,106
8/23/2023	Bobak R. Azamian	CEO	Sell	8,000	$17.23	$137,840.00	902,106
8/15/2023	Elizabeth Yeu Lin	Director	Buy	9,506	$16.80	$159,700.80	15,866
7/19/2023	Aziz Mottiwala	Insider	Sell	2,400	$20.05	$48,120.00	45,806
7/19/2023	Bobak R. Azamian	CEO	Sell	103,900	$20.01	$2,079,039.00	910,106
7/12/2023	Bobak R. Azamian	CEO	Sell	9,000	$17.35	$156,150.00	1,014,006
6/21/2023	Bobak R. Azamian	CEO	Sell	8,000	$18.63	$149,040.00	1,023,006
6/14/2023	Bobak R. Azamian	CEO	Sell	9,000	$18.58	$167,220.00	1,031,006
6/8/2023	Aziz Mottiwala	Insider	Sell	100	$20.00	$2,000.00	48,086
6/8/2023	Bobak R. Azamian	CEO	Sell	3,100	$20.01	$62,031.00	1,040,006
6/6/2023	Aziz Mottiwala	Insider	Sell	2,143	$18.61	$39,881.23	50,686
5/17/2023	Bobak R. Azamian	CEO	Sell	8,000	$15.90	$127,200.00	1,043,106
5/10/2023	Bobak R. Azamian	CEO	Sell	9,000	$16.80	$151,200.00	1,051,106
5/1/2023	Bobak R. Azamian	CEO	Sell	5,841	$15.10	$88,199.10	1,060,106
4/28/2023	Bobak R. Azamian	CEO	Sell	4,278	$15.13	$64,726.14	1,065,947
4/21/2023	Bobak R. Azamian	CEO	Sell	2,311	$15.03	$34,734.33	1,070,225
4/20/2023	Leonard M Greenstein	CFO	Sell	5,000	$14.02	$70,100.00	26,785
4/19/2023	Bobak R. Azamian	CEO	Sell	8,000	$13.60	$108,800.00	1,072,536
3/22/2023	Bobak R. Azamian	CEO	Sell	709	$12.64	$8,961.76	9,334
3/22/2023	Bryan Wahl	General Counsel	Sell	357	$12.64	$4,512.48	16,773
3/22/2023	Jose M Trevejo	Insider	Sell	529	$12.64	$6,686.56	6,572
3/22/2023	Leonard M Greenstein	CFO	Sell	332	$12.64	$4,196.48	32,131
3/22/2023	Seshadri Neervannan	COO	Sell	379	$12.64	$4,790.56	55,086
3/20/2023	Bobak R. Azamian	CEO	Sell	741	$12.61	$9,344.01	10,722
3/20/2023	Bryan Wahl	General Counsel	Sell	357	$12.61	$4,501.77	17,480
3/20/2023	Jose M Trevejo	Insider	Sell	530	$12.61	$6,683.30	7,620
3/20/2023	Leonard M Greenstein	CFO	Sell	333	$12.61	$4,199.13	32,789
3/20/2023	Mark J Holdbrook	VP	Sell	198	$12.61	$2,496.78	3,191
3/20/2023	Seshadri Neervannan	COO	Sell	380	$12.61	$4,791.80	55,837
3/17/2023	Bobak R. Azamian	CEO	Sell	795	$13.28	$10,557.60	11,463
3/16/2023	Bryan Wahl	General Counsel	Sell	337	$13.43	$4,525.91	18,176
3/16/2023	Dianne C Whitfield	Insider	Sell	313	$13.43	$4,203.59	12,872
3/16/2023	Leonard M Greenstein	CFO	Sell	5,313	$13.44	$71,406.72	33,438
3/16/2023	Mark J Holdbrook	VP	Sell	187	$13.43	$2,511.41	3,577
3/16/2023	Seshadri Neervannan	COO	Sell	357	$13.43	$4,794.51	56,577
3/15/2023	Bobak R. Azamian	CEO	Sell	8,000	$13.79	$110,320.00	1,080,536
3/8/2023	Bobak R. Azamian	CEO	Sell	4,853	$15.02	$72,892.06	1,089,253
2/8/2023	Bobak R. Azamian	CEO	Sell	9,000	$15.14	$136,260.00	1,102,106
1/23/2023	Bobak R. Azamian	CEO	Sell	4,856	$15.45	$75,025.20	1,111,106
1/20/2023	Bobak R. Azamian	CEO	Sell	240	$15.00	$3,600.00	1,116,373
1/19/2023	Leonard M Greenstein	CFO	Sell	5,000	$14.56	$72,800.00	39,289
1/18/2023	Bobak R. Azamian	CEO	Sell	8,000	$14.56	$116,480.00	1,116,613
1/11/2023	Bobak R. Azamian	CEO	Sell	3,904	$15.11	$58,989.44	1,124,613
1/9/2023	Bobak R. Azamian	CEO	Sell	729	$15.15	$11,044.35	1,129,422
1/6/2023	Bobak R. Azamian	CEO	Sell	411	$15.00	$6,165.00	1,129,740
12/21/2022	Bobak R. Azamian	CEO	Sell	8,000	$14.57	$116,560.00	1,130,151
12/16/2022	Bobak R. Azamian	CEO	Sell	535	$15.01	$8,030.35	1,138,151
12/15/2022	Leonard M Greenstein	CFO	Sell	5,000	$14.64	$73,200.00	44,289
12/14/2022	Bobak R. Azamian	CEO	Sell	6,420	$15.08	$96,813.60	1,138,686
12/2/2022	Dianne C Whitfield	Insider	Sell	1,154	$16.90	$19,502.60	8,723
11/30/2022	Bryan Wahl	General Counsel	Sell	1,183	$16.50	$19,519.50	16,041
11/30/2022	Dianne C Whitfield	Insider	Sell	1,182	$16.50	$19,503.00	11,042
11/15/2022	Aziz Mottiwala	Insider	Sell	6,857	$17.72	$121,506.04	49,729
10/20/2022	Leonard M Greenstein	CFO	Sell	5,000	$15.92	$79,600.00	54,289
10/19/2022	Bobak R. Azamian	CEO	Sell	8,000	$16.92	$135,360.00	1,162,106
10/12/2022	Bobak R. Azamian	CEO	Sell	9,000	$15.91	$143,190.00	1,170,106
9/21/2022	Bobak R. Azamian	CEO	Sell	8,000	$16.31	$130,480.00	1,179,106
9/15/2022	Leonard M Greenstein	CFO	Sell	5,000	$16.03	$80,150.00	59,289
9/14/2022	Bobak R. Azamian	CEO	Sell	9,000	$16.01	$144,090.00	1,187,106
9/14/2022	Elizabeth Yeu Lin	Director	Buy	18,400	$16.12	$296,608.00	12,040
8/18/2022	Leonard M Greenstein	CFO	Sell	5,000	$16.30	$81,500.00	64,289
8/17/2022	Bobak R. Azamian	CEO	Sell	8,000	$16.59	$132,720.00	1,196,106
5/5/2022	D. Michael Ackermann	Director	Buy	100,000	$13.50	$1,350,000.00	100,000
5/4/2022	Vivo Capital Ix, Llc	Major Shareholder	Sell	19,738	$12.67	$250,080.46	2,474,375
5/2/2022	Vivo Capital Ix, Llc	Major Shareholder	Sell	41,800	$15.19	$634,942.00	2,945,531
12/1/2021	D. Michael Ackermann	Director	Sell	5,833	$24.68	$143,958.44
11/8/2021	Aziz Mottiwala	Insider	Sell	1,889	$28.11	$53,099.79
11/4/2021	Aziz Mottiwala	Insider	Sell	100	$28.03	$2,803.00
11/2/2021	Aziz Mottiwala	Insider	Sell	6,000	$26.78	$160,680.00
11/1/2021	D. Michael Ackermann	Director	Sell	5,833	$27.82	$162,274.06
10/12/2021	Bobak R. Azamian	CEO	Sell	5,531	$26.30	$145,465.30
10/12/2021	D. Michael Ackermann	Director	Sell	5,633	$26.27	$147,978.91
10/8/2021	Bobak R. Azamian	CEO	Sell	302	$25.02	$7,556.04
10/8/2021	D. Michael Ackermann	Director	Sell	200	$25.03	$5,006.00
9/10/2021	Aziz Mottiwala	Insider	Sell	2,593	$22.15	$57,434.95	58,203
9/1/2021	D. Michael Ackermann	Director	Sell	5,833	$25.24	$147,224.92	1,221,515
8/11/2021	Bobak R. Azamian	CEO	Sell	1,917	$25.07	$48,059.19	1,750
8/11/2021	D. Michael Ackermann	Director	Sell	621	$25.15	$15,618.15	1,227,348
8/9/2021	Bobak R. Azamian	CEO	Sell	827	$25.02	$20,691.54	1,750
8/9/2021	D. Michael Ackermann	Director	Sell	700	$25.00	$17,500.00
8/6/2021	D. Michael Ackermann	Director	Sell	3,129	$25.00	$78,225.00
8/5/2021	Bobak R. Azamian	CEO	Sell	1,370	$25.00	$34,250.00
6/25/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	7,704	$29.60	$228,038.40
6/23/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	37,980	$29.80	$1,131,804.00
6/21/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	91,620	$29.70	$2,721,114.00
5/7/2021	Rtw Investments, Lp	Major Shareholder	Sell	450,000	$29.98	$13,491,000.00

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

From Banyan Hill Publishing | Ad

See how you can invest alongside him

SEC Filings (Institutional Ownership Changes) for Tarsus Pharmaceuticals (NASDAQ:TARS)

90.01% of Tarsus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tarsus Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	Nations Financial Group Inc. IA ADV	6,000	$0.22M	0.0%	N/A	0.018%
4/23/2024	Raymond James Financial Services Advisors Inc.	50,950	$1.85M	0.0%	+16.3%	0.149%
4/22/2024	Vivo Capital LLC	565,550	$20.56M	1.6%	-68.3%	1.653%
4/18/2024	Allspring Global Investments Holdings LLC	192,303	$6.99M	0.0%	+2.6%	0.562%
2/14/2024	TFG Asset Management GP Ltd	800,000	$16.20M	3.9%	+30.1%	2.417%
2/14/2024	RTW Investments LP	3,152,341	$63.84M	1.0%	+9.4%	9.524%
2/13/2024	Tower Research Capital LLC TRC	4,560	$92K	0.0%	+22.1%	0.014%
2/12/2024	Artisan Partners Limited Partnership	390,011	$7.90M	0.0%	-2.3%	1.178%
2/9/2024	Trexquant Investment LP	39,497	$0.80M	0.0%	N/A	0.119%
2/8/2024	Janney Montgomery Scott LLC	24,227	$0.49M	0.0%	+11.5%	0.073%
2/7/2024	Ieq Capital LLC	17,754	$0.36M	0.0%	+63.5%	0.054%
2/7/2024	Vivo Capital LLC	1,784,006	$36.13M	3.0%	-21.1%	5.390%
2/6/2024	Swiss National Bank	41,833	$0.85M	0.0%	-15.4%	0.126%
2/5/2024	Sargent Investment Group LLC	11,117	$0.23M	0.0%	N/A	0.034%
2/2/2024	Callan Capital LLC	16,950	$0.34M	0.0%	+11.5%	0.051%
1/31/2024	abrdn plc	72,032	$1.46M	0.0%	N/A	0.218%
1/25/2024	Allspring Global Investments Holdings LLC	187,414	$3.80M	0.0%	-23.8%	0.566%
1/24/2024	China Universal Asset Management Co. Ltd.	3,832	$78K	0.0%	+362.8%	0.012%
1/16/2024	Raymond James Financial Services Advisors Inc.	43,819	$0.89M	0.0%	+42.9%	0.132%
1/12/2024	SG Americas Securities LLC	54,979	$1.11M	0.0%	+8.4%	0.166%
12/18/2023	Vanguard Group Inc.	1,551,802	$27.58M	0.0%	+25.6%	4.688%
12/6/2023	Citigroup Inc.	4,150	$74K	0.0%	-48.5%	0.013%
11/15/2023	RTW Investments LP	2,880,701	$51.19M	1.1%	+13.1%	8.702%
11/15/2023	Alps Advisors Inc.	24,105	$0.43M	0.0%	+22.4%	0.073%
11/14/2023	Schonfeld Strategic Advisors LLC	244,155	$4.34M	0.0%	N/A	0.738%
11/14/2023	Deerfield Management Company L.P. Series C	754,042	$13.40M	0.3%	N/A	2.278%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	40,701	$0.72M	0.0%	N/A	0.123%
11/13/2023	Hsbc Holdings PLC	12,903	$0.22M	0.0%	-18.1%	0.039%
11/9/2023	Cowen AND Company LLC	1,796,773	$31.93M	2.3%	-10.1%	5.508%
11/9/2023	Artisan Partners Limited Partnership	399,177	$7.09M	0.0%	N/A	1.224%
11/8/2023	Swiss National Bank	49,433	$0.88M	0.0%	+41.5%	0.152%
11/8/2023	Oppenheimer & Co. Inc.	21,021	$0.37M	0.0%	N/A	0.064%
11/7/2023	New York State Common Retirement Fund	26,566	$0.47M	0.0%	+145.0%	0.081%
11/7/2023	Barclays PLC	11,637	$0.21M	0.0%	-22.2%	0.036%
11/6/2023	Ieq Capital LLC	10,859	$0.19M	0.0%	N/A	0.033%
10/27/2023	Allspring Global Investments Holdings LLC	245,972	$4.37M	0.0%	+2,784.6%	0.754%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	11,163	$0.20M	0.0%	N/A	0.034%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	5,306	$94K	0.0%	+65.1%	0.016%
10/24/2023	Raymond James Financial Services Advisors Inc.	30,657	$0.55M	0.0%	+81.9%	0.094%
10/24/2023	Raymond James & Associates	10,111	$0.18M	0.0%	N/A	0.031%
10/13/2023	SG Americas Securities LLC	50,713	$0.90M	0.0%	+22.0%	0.155%
8/14/2023	Jefferies Financial Group Inc.	355,758	$6.43M	0.1%	-20.2%	1.091%
8/11/2023	ExodusPoint Capital Management LP	194,821	$3.52M	0.0%	N/A	0.727%
8/7/2023	Cowen AND Company LLC	1,999,383	$36.13M	3.0%	N/A	7.460%
8/4/2023	American International Group Inc.	11,349	$0.21M	0.0%	+27.9%	0.042%
8/4/2023	Cibc World Markets Corp	50,000	$0.90M	0.0%	N/A	0.187%
8/4/2023	Simplex Trading LLC	5,383	$97K	0.0%	N/A	0.020%
7/31/2023	Sargent Investment Group LLC	10,045	$0.18M	0.0%	-5.0%	0.037%
7/26/2023	Janney Montgomery Scott LLC	21,727	$0.39M	0.0%	N/A	0.081%
7/25/2023	Raymond James Financial Services Advisors Inc.	16,856	$0.31M	0.0%	N/A	0.063%
7/24/2023	Allspring Global Investments Holdings LLC	8,527	$0.15M	0.0%	-19.0%	0.032%
7/19/2023	Grant GrossMendelsohn LLC	53,625	$0.94M	0.4%	N/A	0.200%
7/18/2023	Allspring Global Investments Holdings LLC	8,527	$0.15M	0.0%	-19.0%	0.032%
7/10/2023	SG Americas Securities LLC	41,572	$0.75M	0.0%	N/A	0.155%
6/13/2023	Callan Capital LLC	14,300	$0.18M	0.0%	+23.3%	0.053%
6/1/2023	Prelude Capital Management LLC	17,365	$0.22M	0.0%	-6.5%	0.065%
6/1/2023	Macquarie Group Ltd.	150,000	$1.89M	0.0%	-13.2%	0.560%
5/15/2023	Rubric Capital Management LP	221,488	$2.78M	0.1%	-22.2%	0.829%
5/10/2023	TimesSquare Capital Management LLC	1,192,660	$14.99M	0.2%	-16.6%	4.462%
5/9/2023	Callan Capital LLC	14,300	$0.18M	0.0%	+23.3%	0.053%
4/27/2023	Strs Ohio	3,800	$47K	0.0%	-83.5%	0.014%
4/18/2023	Assenagon Asset Management S.A.	146,194	$1.84M	0.0%	-20.2%	0.547%
2/15/2023	Tang Capital Management LLC	2,001,585	$29.34M	4.3%	-4.2%	7.505%
2/15/2023	Jefferies Financial Group Inc.	445,758	$6.54M	0.0%	N/A	1.671%
2/13/2023	Callan Capital LLC	11,600	$0.17M	0.0%	N/A	0.043%
2/10/2023	TimesSquare Capital Management LLC	1,429,310	$20.95M	0.3%	-6.0%	5.359%
2/8/2023	Swiss National Bank	41,833	$0.61M	0.0%	N/A	0.157%
2/1/2023	Janney Montgomery Scott LLC	11,640	$0.17M	0.0%	N/A	0.044%
1/26/2023	Strs Ohio	23,100	$0.34M	0.0%	-17.5%	0.087%
1/12/2023	Assenagon Asset Management S.A.	183,208	$2.69M	0.0%	-9.5%	0.687%
11/15/2022	Tang Capital Management LLC	2,089,856	$35.78M	4.4%	+0.3%	7.835%
11/14/2022	RTW Investments LP	2,023,179	$34.64M	0.8%	+0.5%	7.585%
11/14/2022	Cormorant Asset Management LP	1,971,422	$33.75M	2.4%	+5.1%	7.391%
11/14/2022	Vivo Capital LLC	2,262,200	$38.73M	4.3%	-2.2%	8.482%
11/14/2022	Rubric Capital Management LP	284,732	$4.88M	0.2%	+40.5%	1.068%
11/14/2022	UBS Oconnor LLC	61,000	$1.04M	0.0%	N/A	0.229%
11/7/2022	Jump Financial LLC	12,300	$0.21M	0.0%	-48.8%	0.046%
10/27/2022	Sargent Investment Group LLC	10,858	$0.19M	0.1%	N/A	0.041%
10/27/2022	Assenagon Asset Management S.A.	202,425	$3.47M	0.0%	-44.0%	0.759%
10/26/2022	Allspring Global Investments Holdings LLC	10,683	$0.18M	0.0%	-9.9%	0.040%
8/24/2022	Prelude Capital Management LLC	19,049	$0.28M	0.0%	N/A	0.071%
8/16/2022	Deerfield Management Company L.P. Series C	1,324,214	$19.33M	0.4%	N/A	4.967%
8/15/2022	Vivo Capital LLC	2,312,368	$33.76M	3.4%	-22.6%	11.156%
8/11/2022	Martingale Asset Management L P	14,349	$0.21M	0.0%	N/A	0.069%
8/10/2022	Frazier Life Sciences Management L.P.	1,787,527	$26.10M	2.5%	+26.1%	8.624%
8/5/2022	State Board of Administration of Florida Retirement System	13,170	$0.19M	0.0%	N/A	0.064%
8/5/2022	TimesSquare Capital Management LLC	1,481,710	$21.63M	0.3%	+124.6%	7.148%
7/29/2022	SG Americas Securities LLC	50,512	$0.74M	0.0%	+19.0%	0.244%
7/27/2022	Assenagon Asset Management S.A.	361,741	$5.28M	0.0%	N/A	1.745%
7/25/2022	Allspring Global Investments Holdings LLC	11,860	$0.17M	0.0%	-7.1%	0.057%
7/25/2022	Strs Ohio	28,000	$0.41M	0.0%	+1,233.3%	0.135%
5/16/2022	J. Goldman & Co LP	10,544	$0.18M	0.0%	N/A	0.051%
5/16/2022	Frazier Life Sciences Management L.P.	1,417,157	$23.84M	2.0%	N/A	6.837%
5/16/2022	Ghost Tree Capital LLC	120,000	$2.02M	0.4%	-29.4%	0.579%
5/13/2022	DLD Asset Management LP	32,500	$0.55M	0.0%	N/A	0.157%
5/6/2022	TimesSquare Capital Management LLC	659,600	$11.09M	0.1%	-0.2%	3.182%
4/29/2022	SG Americas Securities LLC	42,439	$0.71M	0.0%	-4.3%	0.205%
2/11/2022	Ensign Peak Advisors Inc	242,451	$5.46M	0.0%	+21.2%	1.173%
2/8/2022	Northern Trust Corp	71,781	$1.62M	0.0%	-3.0%	0.347%
2/7/2022	SG Americas Securities LLC	44,330	$1M	0.0%	-4.2%	0.214%

Data available starting January 2016

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Today's Range

Now: $33.71

$32.14

$34.11

50 Day Range

MA: $33.94

$29.43

$39.22

52 Week Range

Now: $33.71

$12.57

$40.40

Volume

230,724 shs

Average Volume

731,767 shs

Market Capitalization

$1.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Tarsus Pharmaceuticals?: Tarsus Pharmaceuticals' top insider shareholders include:
Vivo Capital Ix, Llc (Major Shareholder)
Bobak R Azamian (CEO)
Michael Ackermann (Director)
Seshadri Neervannan (COO)
Leonard M Greenstein (CFO)
Aziz Mottiwala (Insider)
Bryan Wahl (General Counsel)
Dianne C Whitfield (Insider)
Elizabeth Yeu Lin (Director)
Jose M Trevejo (Insider)
Mark J Holdbrook (VP)
Andrew D Goldberg (Director)
Learn More about top insider investors at Tarsus Pharmaceuticals.
Who are the major institutional investors of Tarsus Pharmaceuticals?: Tarsus Pharmaceuticals' top institutional shareholders include:
Vivo Capital LLC — 1.65%
Allspring Global Investments Holdings LLC — 0.56%
Raymond James Financial Services Advisors Inc. — 0.15%
Nations Financial Group Inc. IA ADV — 0.02%
Learn More about top institutional investors of Tarsus Pharmaceuticals stock.
Which institutional investors are selling Tarsus Pharmaceuticals stock?: Within the last quarter, TARS stock was sold by these institutional investors:
Vivo Capital LLC
In the last year, company insiders that have sold Tarsus Pharmaceuticals company stock include:
Vivo Capital Ix, Llc (Major Shareholder)
Bobak R Azamian (CEO)
Michael Ackermann (Director)
Seshadri Neervannan (COO)
Leonard M Greenstein (CFO)
Aziz Mottiwala (Insider)
Learn More investors selling Tarsus Pharmaceuticals stock.
Which institutional investors are buying Tarsus Pharmaceuticals stock?: In the previous quarter, TARS stock was acquired by institutional investors including:
Raymond James Financial Services Advisors Inc.
Nations Financial Group Inc. IA ADV
Allspring Global Investments Holdings LLC
Within the last year, these company insiders have bought Tarsus Pharmaceuticals stock:
Vivo Capital Ix, Llc (Major Shareholder)
Bobak R Azamian (CEO)
Michael Ackermann (Director)
Learn More investors buying Tarsus Pharmaceuticals stock.